Skip to main content
Clinical Trials/NCT01702116
NCT01702116
Unknown
Not Applicable

Multicenter Randomized Controlled Trial, Extralevator Versus Standard Abdominoperineal Resection For Rectal Adenocarcinoma

Stony Brook University3 sites in 1 country34 target enrollmentJuly 2011

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Rectal Adenocarcinoma
Sponsor
Stony Brook University
Enrollment
34
Locations
3
Primary Endpoint
measurement of circumferential resection margin
Last Updated
13 years ago

Overview

Brief Summary

This is a study that compares two types of surgery for rectal cancer. There are two procedures that can be used during this surgery, conventional abdominal resection (APR) and extended (or extralevator) APR. The investigators are doing this research to see whether the extralevator APR increases the likelihood that the edge of the tissue that is removed will be more likely to be free from cancer cells compared with the conventional APR surgery. At this time there is no evidence that one type of procedure is better at this than the other. The objective of this research is to determine whether extralevator APR is more likely to have clean margins (free of cancer) compared to the standard APR surgery.

Registry
clinicaltrials.gov
Start Date
July 2011
End Date
July 2013
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Roberto Bergamaschi

Professor and Chief, Colon and Rectal Surgery

Stony Brook University

Eligibility Criteria

Inclusion Criteria

  • Resectable, histologically proven primary adenocarcinoma of the low rectum with internal and/or external sphincter muscle involvement. Staged as follows prior to neoadjuvant chemoradiation:
  • Stage T3 or T4 at MRI
  • N0-2 at MRI
  • M0 at CT scan
  • Patient must undergo long term neoadjuvant chemoradiation: 20 fractions of radiation over ≥5 weeks: total of 50-60 Gy, and chemotherapeutic agents

Exclusion Criteria

  • Squamous cell carcinoma
  • Adenocarcinoma Stage T1-2, any N
  • T4 with one of the following:
  • with pelvic side wall involvement requiring sacrectomy requiring prostatectomy (partial or total) Distant metastasis (M1) Unresectable primary rectal cancer or Inability to complete R0 resection. Recurrent rectal cancer Previous pelvic malignancy Inability to sign informed consent Pregnancy

Outcomes

Primary Outcomes

measurement of circumferential resection margin

Time Frame: 0-10 minutes post surgery

Measurement in millimeters (mm) of the circumferential resection margin.

Secondary Outcomes

  • operative time(4-6 hours)
  • hospital stay(from beginning of surgery through discharge, usually 4-5 days)
  • estimated blood loss(4-6 hours)

Study Sites (3)

Loading locations...

Similar Trials